Bram Goorden is a CEO and non-executive board director with extensive expertise in building life sciences organisations and in setting and implementing a strategy for shareholder value through growth, innovation, and sound financial plans. They have experience with corporate turnarounds, M&A, scale-ups, IPOs, and leading publicly listed companies, and are passionate about progressing healthcare and patient impact in areas of unmet need. Currently, they serve on the boards of Oncobit AG and Zetta Genomics Ltd, and hold executive and board roles at IXICO (CEO | Board Director), Mantis Photonics AB (Chairman of the Board), and VirdisGroup (Chairman of the Advisory Board). Their past leadership included roles as Chief Operating Officer at SOPHiA GENETICS (2020-2022) and Eagle Genomics (2022-2024), President International Business at Foundation Medicine (2017-2020), Vice President Novel Therapeutics/CEO Prometheus Labs at Nestlé Health Science (2012-2017), and positions at UCB, Eli Lilly and Company, and Accenture; they completed the Harvard Business School program Changing the Game in 2016.
Location
Geneva, Switzerland
This person is not in the org chart
This person is not in any teams
This person is not in any offices